Market Research

Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.

The Psychedelics Industry Hit Major Highs and Lows in 2024

The psychedelics industry witnessed notable milestones and setbacks at both the state and federal levels in 2024. Here’s a detailed look at some of the most significant events of the year. Department of Veterans Affairs Funds Psychedelic Research for Veterans In a landmark move, the Department of Veterans Affairs (VA) announced a $1.5 million investment…

VA Awards $1.5M To Study MDMA for PTSD

Veterans Affairs officials announced on Tuesday a $1.5 million grant to explore MDMA-assisted therapy as a treatment for post-traumatic stress disorder (PTSD) and alcohol use disorder among veterans. This marks the department’s first government-funded research into the potential benefits of psychedelics in over 50 years. Earlier this year, the VA revealed plans to study the…

Cannabis for PTSD: MAPS’ MJP2 Trial Approved

In a pivotal achievement for mental health and cannabis research, the Multidisciplinary Association for Psychedelic Studies (MAPS) has overcome substantial regulatory barriers to advance its Phase 2 clinical trial, known as MJP2. This groundbreaking study examines the effects of smoked and vaporized cannabis on post-traumatic stress disorder (PTSD). After years of rigorous advocacy, scientific preparation,…

How the Eudēmonia Summit Has Already Improved My Life

And why everyone should go to this conference in 2025. I walked into the Palm Beach County Convention Center on November 1st bursting with curiosity. The health and wellness conference I was there to take part in, called The Eudēmonia Summit, was the first of its kind. It was a name I hadn’t heard before…